Genetic connections between neurological disorders and cholesterol metabolism

Ingemar Björkhem, Valerio Leoni, Steve Meaney

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Cholesterol is an essential component of both the peripheral and central nervous systems of mammals. Over the last decade, evidence has accumulated that disturbances in cholesterol metabolism are associated with the development of various neurological conditions. In addition to genetically defined defects in cholesterol synthesis, which will be covered in another review in this Thematic Series, defects in cholesterol metabolism (cerebrotendinous xanthomatosis) and intracellular transport (Niemann Pick Syndrome) lead to neurological disease. A subform of hereditary spastic paresis (type SPG5) and Huntington's disease are neurological diseases with mutations in genes that are of importance for cholesterol metabolism. Neurodegeneration is generally associated with disturbances in cholesterol metabolism, and presence of the E4 isoform of the cholesterol transporter apolipoprotein E as well as hypercholesterolemia are important risk factors for development of Alzheimer's disease. In the present review, we discuss the links between genetic disturbances in cholesterol metabolism and the above neurological disorders.

Original languageEnglish
Pages (from-to)2489-2503
Number of pages15
JournalJournal of Lipid Research
Volume51
Issue number9
DOIs
Publication statusPublished - Sep 2010

Fingerprint

Nervous System Diseases
Metabolism
Cholesterol
Cerebrotendinous Xanthomatosis
Defects
Mammals
Muscle Spasticity
Huntington Disease
Peripheral Nervous System
Neurology
Apolipoproteins E
Paresis
Hypercholesterolemia
Alzheimer Disease
Protein Isoforms
Central Nervous System
Genes
Mutation

Keywords

  • Alzheimer's disease
  • Cholesterol/metabolism
  • Cholesterol/trafficking
  • Lipoproteins/assembly
  • Nuclear receptors
  • Omega oxidation

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology
  • Endocrinology

Cite this

Genetic connections between neurological disorders and cholesterol metabolism. / Björkhem, Ingemar; Leoni, Valerio; Meaney, Steve.

In: Journal of Lipid Research, Vol. 51, No. 9, 09.2010, p. 2489-2503.

Research output: Contribution to journalArticle

Björkhem, Ingemar ; Leoni, Valerio ; Meaney, Steve. / Genetic connections between neurological disorders and cholesterol metabolism. In: Journal of Lipid Research. 2010 ; Vol. 51, No. 9. pp. 2489-2503.
@article{a02d697aa0ce48519914bafc3fd4a8d8,
title = "Genetic connections between neurological disorders and cholesterol metabolism",
abstract = "Cholesterol is an essential component of both the peripheral and central nervous systems of mammals. Over the last decade, evidence has accumulated that disturbances in cholesterol metabolism are associated with the development of various neurological conditions. In addition to genetically defined defects in cholesterol synthesis, which will be covered in another review in this Thematic Series, defects in cholesterol metabolism (cerebrotendinous xanthomatosis) and intracellular transport (Niemann Pick Syndrome) lead to neurological disease. A subform of hereditary spastic paresis (type SPG5) and Huntington's disease are neurological diseases with mutations in genes that are of importance for cholesterol metabolism. Neurodegeneration is generally associated with disturbances in cholesterol metabolism, and presence of the E4 isoform of the cholesterol transporter apolipoprotein E as well as hypercholesterolemia are important risk factors for development of Alzheimer's disease. In the present review, we discuss the links between genetic disturbances in cholesterol metabolism and the above neurological disorders.",
keywords = "Alzheimer's disease, Cholesterol/metabolism, Cholesterol/trafficking, Lipoproteins/assembly, Nuclear receptors, Omega oxidation",
author = "Ingemar Bj{\"o}rkhem and Valerio Leoni and Steve Meaney",
year = "2010",
month = "9",
doi = "10.1194/jlr.R006338",
language = "English",
volume = "51",
pages = "2489--2503",
journal = "Journal of Lipid Research",
issn = "0022-2275",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "9",

}

TY - JOUR

T1 - Genetic connections between neurological disorders and cholesterol metabolism

AU - Björkhem, Ingemar

AU - Leoni, Valerio

AU - Meaney, Steve

PY - 2010/9

Y1 - 2010/9

N2 - Cholesterol is an essential component of both the peripheral and central nervous systems of mammals. Over the last decade, evidence has accumulated that disturbances in cholesterol metabolism are associated with the development of various neurological conditions. In addition to genetically defined defects in cholesterol synthesis, which will be covered in another review in this Thematic Series, defects in cholesterol metabolism (cerebrotendinous xanthomatosis) and intracellular transport (Niemann Pick Syndrome) lead to neurological disease. A subform of hereditary spastic paresis (type SPG5) and Huntington's disease are neurological diseases with mutations in genes that are of importance for cholesterol metabolism. Neurodegeneration is generally associated with disturbances in cholesterol metabolism, and presence of the E4 isoform of the cholesterol transporter apolipoprotein E as well as hypercholesterolemia are important risk factors for development of Alzheimer's disease. In the present review, we discuss the links between genetic disturbances in cholesterol metabolism and the above neurological disorders.

AB - Cholesterol is an essential component of both the peripheral and central nervous systems of mammals. Over the last decade, evidence has accumulated that disturbances in cholesterol metabolism are associated with the development of various neurological conditions. In addition to genetically defined defects in cholesterol synthesis, which will be covered in another review in this Thematic Series, defects in cholesterol metabolism (cerebrotendinous xanthomatosis) and intracellular transport (Niemann Pick Syndrome) lead to neurological disease. A subform of hereditary spastic paresis (type SPG5) and Huntington's disease are neurological diseases with mutations in genes that are of importance for cholesterol metabolism. Neurodegeneration is generally associated with disturbances in cholesterol metabolism, and presence of the E4 isoform of the cholesterol transporter apolipoprotein E as well as hypercholesterolemia are important risk factors for development of Alzheimer's disease. In the present review, we discuss the links between genetic disturbances in cholesterol metabolism and the above neurological disorders.

KW - Alzheimer's disease

KW - Cholesterol/metabolism

KW - Cholesterol/trafficking

KW - Lipoproteins/assembly

KW - Nuclear receptors

KW - Omega oxidation

UR - http://www.scopus.com/inward/record.url?scp=77955108799&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955108799&partnerID=8YFLogxK

U2 - 10.1194/jlr.R006338

DO - 10.1194/jlr.R006338

M3 - Article

VL - 51

SP - 2489

EP - 2503

JO - Journal of Lipid Research

JF - Journal of Lipid Research

SN - 0022-2275

IS - 9

ER -